Production must be scaled up to meet patient demand for cell therapies while ensuring product quality and safety. Productive manufacturing techniques can lower charges while increasing accessibility. The biggest challenges include keeping cell quality consistent, following standards, and fabricating huge quantities at a high cost. Experts are implementing standardized protocols, streamlining systems, and improving cultural conditions to improve scalability and expedite manufacturing steps.